Cancer Diagnostics – Products
Ellutia Introduces Fully Automated Total Nitrosamine Testing for Pharmaceuticals
Ellutia has produced a fully automated process for better safety, higher throughput and user-friendliness.
Yourgene Health Launches LightBench Detect for Fetal Fraction Enrichment
Yourgene Health plc announces today the launch of the LightBench® Detect, the latest addition to its Ranger® Technology instrumentation portfolio at the 26th International Conference on Prenatal Diagnosis and Therapy.
SomaLogic Announces License Agreement With OncoHost for the Development of Precision Cancer Diagnostics
SomaLogic has announced it has signed a licensing agreement with OncoHost.
Aptamers for Cancer Diagnosis and Therapy
AMSBIO offer an extensive range of aptamers targeting many human proteins linked to cancer.
Personalis Announces Issuance of Additional US Patent Related to the NeXT Personal™ Platform
Personalis has announced the issuance of a key US Patent related to its industry-leading minimal residual disease (MRD) and recurrence platform, NeXT Personal.
Article Describes Gene Signature Ratio that Predicts Survival in Colon Cancer
Biotech Support Group and Leiden University Medical Center announce publication of a journal article based upon on their joint goal to correlate BSG’s patent pending Stroma Liquid Biopsy™ panel of blood-borne biomarkers, to tissue derived tumor-stroma ratio scoring methods.
Circulating Tumor Cell (CTC) Enumeration Overcomes Limitations of Other Blood-Based Cancer Detection Methods
Liquid biopsies are rapidly gaining traction and becoming a standard of care for cancer. They are an attractive alternative to invasive, painful, costly tissue biopsies and can facilitate real-time monitoring while providing insight into the disease state, even for tissues that are difficult to access, such as brain cancers.
Detecting Cancer’s Methylation Fingerprint in Blood Plasma
With recent advances in cancer detection and prevention, a future where cancer can be cured is starting to feel within reach. One significant area of progress is early detection, which can go a long way toward eliminating cancer.
Thermo Fisher Scientific Unveils Q Digital PCR System for Innovation in Genetic Analysis Capabilities and Higher Research
Thermo Fisher Scientific, the world leader in serving science, has introduced the Applied Biosystem QuantStudio Absolute Q-Digital PCR System, the first fully integrated digital PCR (dPCR) system designed to provide highly accurate and consistent results within 90 minutes.
Loughborough MP Officially Opens Former Lighthouse Lab at Charnwood Campus
A state-of-the-art former Lighthouse Lab at the Charnwood Campus was officially opened by Jane Hunt MP, having been acquired by the global whole genome sequencing company, Dante Labs.